SCHEMBL896593

SCHEMBL896593

CN(C)CCCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL296056 0.97
Hydrochloric Acid SCHEMBL19922527 0.97
SCHEMBL9491702 0.90
SCHEMBL29165313 0.87 ALDH1A1 (0.69)
SCHEMBL25807553 0.79 CHRM2 (0.43)
SCHEMBL308533 0.77
SCHEMBL1290871 0.76 ALDH1A1 (0.75)
SCHEMBL212626 0.76
SCHEMBL21216 0.76 ALDH1A1 (0.91)
Iodide SCHEMBL1034234 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3578575-B1 AN AMINE-BASED POLYMER, A PREPARATION PROCESS THEREOF AND USE THEREOF CHINA PETROLEUM & CHEM CORP (CN) 2023-11-01 EP disclosed
US-20230331692-A1 TRISULFIDE COMPOUND AND CLATHRATE THEREOF KYOWA PHARMA CHEMICAL CO., LTD. (JP) 2023-10-19 US disclosed
WO-2023125376-A1 FUSED BICYCLIC HETEROARYL AMIDE COMPOUND AS PROTEIN AGGREGATION INHIBITOR 上海京新生物医药有限公司 2023-07-06 WO disclosed
EP-3717475-B1 KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE ICAHN SCHOOL MED MOUNT SINAI (US) 2023-06-07 EP disclosed
WO-2023093834-A1 PYRROLIDINE ANTIVIRAL COMPOUND 先声再明医药有限公司 2023-06-01 WO disclosed
EP-3475277-B1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-10-20 EP disclosed
US-20210094950-A1 KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE NATIONAL INSTITUTES OF HEALTH 2021-04-01 US disclosed
WO-2021052499-A1 FUSED PYRIDONE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海济煜医药科技有限公司 2021-03-25 WO disclosed
US-10723760-B2 Method for preparing site-specifically modified protein based on novel carbon-carbon bond formation KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2020-07-28 US disclosed
US-10640502-B2 Therapeutic targeting of interleukin-1 receptor-associated kinase 4 (IRAK4) in cancers characterized by rearrangements in the mixed lineage leukemia gene (MLL-r) NORTHWESTERN UNIVERSITY (US) 2020-05-05 US disclosed
WO-2010114896-A1 SUBSTITUTED INDOLO-PYRIDINONE COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
WO-2009066947-A2 POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, HOMEOTROPIC ALIGNMENT LIQUID CRYSTAL FILM MADE FROM THE COMPOSTION AND METHOD FOR PREPARING THE SAME LG CHEM, LTD. (KR) 2009-05-28 WO disclosed
EP-1777214-A2 Novel aryloxy-alkyl-dialkylamines Wyeth (US) 2007-04-25 EP disclosed
EP-1025077-B1 NOVEL ARYLOXY-ALKYL-DIALKYLAMINES WYETH CORP (US) 2007-02-28 EP disclosed
EP-0111281-B1 NEW CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-06-06 EP disclosed
US-4719206-A ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-01-12 US disclosed
US-4584290-A MICROBIOCIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-04-22 US disclosed
EP-0111281-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-06-20 EP disclosed
US-4355031-A 2,3-Dihydro-3-[4-(substituted)-1-piperazinyl]-1H-isoindol-1-ones AMERICAN HOME PRODUCTS CORP. (US) 1982-10-19 US disclosed
EP-0049779-A1 3-Aminoindazole derivatives and process for preparation thereof Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1982-04-21 EP disclosed